01-01-1970 12:00 AM | Source: Nirmal Bang Ltd
The Nifty50 index settled below the 16,500-mark at 16,488, up 37 points or 0.23% - Nirmal Bang
News By Tags | #879 #9

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Market Review

US: U.S. stock benchmarks booked new records Monday, as investors appeared to wager that the Federal Reserve’s Chairman Jerome Powell will adopt a more dovish posture than previously anticipated when he speaks later this week at the annual Jackson Hole monetary policy symposium.

Asia: Asia Pacific stocks were up on Tuesday morning, with the first full approval for a COVID-19 vaccine expected to boost U.S. vaccination rates and assuaging some concerns over COVID19's impact on the global economic recovery

India: The frontline S&P BSE Sensex index advanced 226 points, or 0.41 %, and closed at 55,556 levels while the Nifty50 index settled below the 16,500-mark at 16,488, up 37 points or 0.23%. In the broader markets, the BSE MidCap and SmallCap indices slipped 0.9% and 1.5%, respectively. Market is expected to open gap up and likely to witness positive move during the day

Economy: U.S. business activity growth slowed for a third straight month in August as capacity constraints, supply shortages and the rapidly spreading Delta variant of the coronavirus weaken the momentum of the rebound from last year's pandemic-induced recession. U.S. Composite PMI Output Index, which tracks the manufacturing and services sectors, fell to 55.4 - the lowest since last December - from 59.9 in July. U.S. existing home sales increased for the second consecutive month in July as inventories improved moderately, while prices eased from the prior month's record level. Existing home sales increased 2.0% to a seasonally adjusted annual rate of 5.99 million units last month from June's upwardly revised pace of 5.87 million units

Commodities: Oil prices rose on Tuesday after the U.S. drug regulator granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, stoking investor hopes that higher fuel demand will follow a potential step up in U.S. coronavirus vaccination rates.

Gold prices fell slightly on Tuesday, although they hovered above the key psychological level of $1,800 on expectations that the U.S. Federal Reserve might delay cutting back its stimulus amid rising cases of the Delta coronavirus variant.

Currency: The dollar was smarting on Tuesday following its sharpest one-day fall since May, though traders were wary of chasing the mood-driven move lower ahead of a Federal Reserve symposium that could map out an end to stimulus and asset purchases.

 

To Read Complete Report & Disclaimer Click Here

 

Please refer disclaimer at https://investmentguruindia.com/Disclaimer/nirmal.html

 

SEBI Registration number is INH000001766

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer.